April 24 Apr 24
2014
Thursday Thu

Framework for Evaluating Preparedness and Response to a Bioterrorism Event

Overview of Quantitative Methods and Tools, and Modeling Strategies in Bioterrorism Preparedness and Response

Framework for evaluating preparedness and response. Evaluation of existing surveillance systems. Model-based evaluation of anthrax syndromic surveillance. Evidence-based Syndromic versus Traditional Surveillance Systems. Modeling of anthrax response: national and local response logistics. Vaccination or antibiotics? Evidence-based approach and literature review. Logistics of Supply Chain Response. 

Location

Li Ka Shing Learning & Knowledge Center (LKSC)
291 Campus Dr.
Palo Alto, CA 94305
USA

Loading Map...

Li Ka Shing Learning & Knowledge Center (LKSC)

291 Campus Dr.
Palo Alto, CA 94305
Get Directions

Speaker

Douglas Owens, MD MS; Director of the Center for Health Policy/Center for Outcomes Research in Primary Care at Stanford; Senior Fellow Freeman-Spogli Institute for International Studies

Douglas K. Owens, MD, MS:  Director of the Center for Health Policy in the Freeman Spogli Institute for International Studies (FSI) and of the Center for Primary Care and Outcomes Research (PCOR) in the Department of Medicine and School of Medicine at Stanford.  He is a general internist and Associate Director of the Center for Health Care Evaluation at the VA Palo Alto Health Care System.  Owens is a Henry J. Kaiser, Jr. professor of medicine and, by courtesy, of health research and policy at Stanford University; and a Senior Fellow at FSI.

Owens also directed the Stanford-UCSF Evidence-based Practice Center and the Program on Clinical Decision Making and Guideline Development at PCOR.  He directs three training programs in health services research: the Fellowship Program in Health Research and Policy at Stanford, the VA Physician Fellowship in Health Services Research, and the VA Postdoctoral Informatics Fellowship Program.

Owens' research focuses on technology assessment, cost-effectiveness analysis, evidence synthesis, and methods for clinical decision making. He is studying the cost-effectiveness of preventive and therapeutic interventions for HIV/AIDS in several countries; diagnostic and therapeutic interventions for cardiovascular disease; approaches to quality improvement; and he has developed methods for developing clinical practice guidelines tailored to specific patient populations. Owens chaired the Clinical Guidelines Committee of the American College of Physicians for four years. The guideline committee develops clinical guidelines that are used widely and are published regularly in the Annals of Internal Medicine.

Owens received a BS and an MS from Stanford University, and an MD from the University of California-San Francisco. He completed a residency in internal medicine at the University of Pennsylvania and a fellowship in health research and policy at Stanford.  Owens is a past-President of the Society for Medical Decision Making.  He received the VA Undersecretary’s Award for Outstanding Achievement in Health Services Research, and the Eisenberg Award for Leadership in Medical Decision Making from the Society for Medical Decision Making.  He was elected to the American Society for Clinical Investigation (ASCI) and the Association of American Physicians (AAP).

David Magnus, PhD. is Thomas A. Raffin Professor of Medicine and Biomedical Ethics, and Professor of Pediatrics at Stanford University, where he directs the Stanford Center for Biomedical Ethics.

David Magnus received his PhD in philosophy from Stanford University, and currently co-chairs Stanford Hospital and Clinic’s Ethics Committee which provides consultation to doctors, patients and families on issues concerning surrogate decision making at the end-of-life and organ donation. He is a member of Stanford’s End of Life Work Group, Palliative Care Board and the newly formed Innovative Care Committee.